This website was discontinued on 20/12/2022. Visit the new website at www.fct.pt.
The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
Lymphoid tissues in HIV-2 infected patients. Ana Espada de Sousa, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €195,000.
Early detection of cancer using serum biomarkers based on aberrant post-translational modifications of O-glycoproteins, O-PTM-Biomarkers. Celso Albuquerque Reis, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €140,000.
The relationship of circulating biomarkers of apoptosis and endothelial function with the plaque composition using VH IVUS. Maria Teresa Ferreira Marques Pinheiro, Instituto Superior Técnico (IST/ULisboa). €155,000.
The ethiology and pathogenesis of venous thrombosis in the Portuguese “in risk” population: From clinical manifestations to identification of hereditary risk and protective factors as well as exogenous or ambiental factors. Dezso David, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €120,000.
Suicide prevention and improved management of common mental health disorders : combined intervention of psychoeducation for patients and training for primary care practitioners. RICARDO DUARTE MIRANDA DE GUSMÃO, Faculdade de Ciências Médicas (FCM/UNL). €82,120.
Lupus and its compensation in unaffected relatives by T-cell regulation. Constantin Fesel, Fundação Calouste Gulbenkian (FCG). €190,000.
Slow and Rapid Progression Parkinson´s Disease: Molecular Determinants and Biomarkers. Tiago Outeiro, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €195,000.
Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact. Mamede de Carvalho, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €193,000.
Risk Assessment in Acute Heart Failure - RAAHF. Paulo Bettencourt, Hospital de São João EPE (HSJ). €120,000.
MODIFIERS OF EXPRESSION OF HEMOCHROMATOSIS: looking for new markers of disease prognosis. Maria da Graça Beça Gonçalves Porto, Instituto de Biologia Molecular e Celular (IBMC/UP). €167,800.
Molecular diagnosis of OTC deficiency: too many unsolved cases. Luísa Cristina da Costa Azevedo, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €120,000.
Neuropsychological predictors of the outcome in non-demented subjects with cognitive complaints. Alexandre Valério de Mendonça, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €61,041.
Crohn's disease and mycobacterial infection. Amélia Maria Marques da Silva Rodrigues Sarmento Assunção, Instituto de Biologia Molecular e Celular (IBMC/UP). €100,000.
“DNA mimics” - Development and application of DNA mimics for the rapid identification of pathogens. Nuno Filipe Azevedo, Faculdade de Engenharia da Universidade do Porto (FE/UP). €125,677.
Prognostic Signatures in Colorectal Cancer (PSCC). Luis Antonio Marques da Costa, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €194,000.
Prognosis and prevention in a few inherited diseases existing in the Portuguese population. Olga Alcina Martins De Oliveira Amaral, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €165,000.
Therapies in familial amyloidotic polyneuropathy. Maria João Gameiro de Mascarenhas Saraiva, Instituto de Biologia Molecular e Celular (IBMC/UP). €170,000.
Trends in incidence and outcome of Neurological Attacks: the second population-based study in Northern Portugal. Manuel Jorge Maia Pereira Correia, Centro Hospitalar Universitário do Porto (CHP/MS). €178,000.
Interference of Mycobacterium tuberculosis with the endocytic/antigen presentation pathways on macrophages and dendritic cells from healthy and immunocompromised donnors. Elsa Maria Ribeiro dos Santos Anes, Associação para o Desenvolvimento do Ensino e Investigação da Microbiologia (ADEIM). €135,000.
Invariant Natural Killer T Cells in Allergic Asthma and Tolerogenic Therapy. Luis Ricardo Silva Graca, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €155,000.
Implicações clínicas dos factores genéticos envolvidos em doenças neurodegenerativas caracterizadas por alterações do movimento ou cognitivas. Isabel Alexandra Azevedo Silveira, Instituto de Biologia Molecular e Celular (IBMC/UP). €123,000.
Cardiovascular risk and inflammation- contribution to the etiopathogenesis of atherosclerosis and cardiovascular disease. João Eurico Cortez Cabral da Fonseca, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €150,000.
Exploring the role of E-Cadherin-HER interaction in the search of molecular biomarkers for the clinical management of gastric cancer patients. Raquel Seruca, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €193,000.
Determinants of left ventricular hypertrophy before and after surgical treatment of aortic stenosis: clinical, morphofunctional, genetic and molecular correlations. Joaquim Adelino Correia Ferreira Leite Moreira, Faculdade de Medicina da Universidade do Porto (FM/UP). €112,000.
Acção da insulina induzida pelo estado pós-prandial - da ciência básica aos estudos clínicos. Maria Paula Borges de Lemos Macedo, Faculdade de Ciências Médicas (FCM/UNL). €140,000.
Food intake, hyperhomocysteinaemia and cardiovascular disease in type 2 diabetic patients. Maria Helena Rodrigues Gonçalves Soares Costa, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €94,000.
Vision and action processing in neurodevelopmental disorders: from disease mechanisms to new interventional strategies. Miguel de Sá e Sousa de Castelo Branco, Universidade de Coimbra (UC). €187,000.
Immunological basis for the association of hypersomnic sleep disorders and cardiovascular disease. LUÍS FILIPE FERREIRA MOITA, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €170,795.
Determinants of the decline in coronary heart disease (CHD) mortality in Portugal, 1987-2000. Ana Azevedo, Faculdade de Medicina da Universidade do Porto (FM/UP). €80,000.
Clinical and Genetic study of X-linked mental retardation (XLMR) in Portugal: validation of a gene panel for diagnosis. Patrícia Espinheira de Sá Maciel, Universidade do Minho (UM). €170,000.
Prevalence of Familial Hypercholesterolaemia and analysis of cardiovascular risk factors in the portuguese populution. Mafalda Bourbon, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €100,000.
Clinical implications of activation of PI3K/Akt signaling pathway in primary adult acute lymphoblastic leukemia. João Mascarenhas Forjaz de Lacerda, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €134,000.
Idiopathic mental retardation: evaluation of a CGH microarray strategy for genetic diagnosis. Patrícia Espinheira de Sá Maciel, Universidade do Minho (UM). €176,000.
Increased cardiovascular risk in chronic renal insufficiency. Role of the novel monoamine-oxidase renalase in the sympathetic and renal dopaminergic activities. Manuel Pestana, Faculdade de Medicina da Universidade do Porto (FM/UP). €88,000.
Mapping of genes predisposing to familial thyroid tumours. Valdemar de Jesus Conde Máximo, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €169,820.
Cardiovascular risks factors for mothers and children 3 years after delivery. Ana Azevedo, Faculdade de Medicina da Universidade do Porto (FM/UP). €170,000.
The differential effect of WT and V30M Transthyretin in the hepatic microenvironment and vasculature response. Rui José Rodrigues Perdigoto, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €190,000.
Implications for therapy and disease presentation of the changes triggered by the use of the pneumococcal 7-valent conjugate vaccine. Mário Nuno Ramos de Almeida Ramirez, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €180,000.
Long-term impact of thymectomy performed in early infancy. Rui Manuel Martins Victorino, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €75,000.
Transcriptional variation of the ATXN3 gene as modulator of the clinical heterogeneity in Machado-Joseph disease (MJD). Maria Manuela de Medeiros Lima, Universidade dos Açores (UAçores). €92,000.
DEVELOPMENT AND VALIDATION OF VASO-OCCLUSION EARLY PREDICTORS IN A MENDELIAN MODEL OF VASCULAR DISEASE. João Lavinha, Pró-INSA, Associação para a Promoção da Investigação em Saúde (Pró-INSA/INSARJ). €185,000.
Diagnosis, Prognosis and Treatment of Cystic Fibrosis. Margarida Sofia Pereira Duarte Amaral, Fundação da Faculdade de Ciências da Universidade de Lisboa, FP (FFC/FC/ULisboa). €170,000.
Whole human genome analysis of genetic imbalances and numerical abnormalities by single-nucleotide polymorphism (SNP)-arrays in gliomas: correlation with clinical and biological features of the disease. Catarina Oliveira, Centro de Neurociências e Biologia Celular (CNBC/UC). €150,440.
Outcome after severe trauma: Implications for the clinical approach. Altamiro Manuel Rodrigues Costa Pereira, Faculdade de Medicina da Universidade do Porto (FM/UP). €62,138.
Study of Helicobacter pylori primary and secondary resistance to antimicrobial agents. JOSÉ MANUEL GODINHO MATOS ROMÃOZINHO, Universidade de Coimbra (UC). €150,000.
Cancer risk and irradiation: an epidemiological and genetic study of a cohort irradiated for Tinea capitis. José Manuel Lopes Teixeira Gomes, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €170,000.
Mechanisms of neurosensorial inhibition associated with the cognitive deficits in Neurofibromatosis type 1: psychophysics, neurophysiology and functional and structural neuroimaging. Eduardo José Gil Duarte Silva, Universidade de Coimbra (UC). €150,000.
Prospective multicentric study on postoperative pain in Portugal. José Manuel Pereira Dias de Castro Lopes, Faculdade de Medicina da Universidade do Porto (FM/UP). €140,000.
Regulation of ZAP-70 and PTEN activity and stability in chronic lymphocytic leukemia: prognostic and therapeutic implications. João Pedro Taborda Barata, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €134,000.
Oxidative stress and genetic markers of cardiovascular risk in hypertension. Patricio Soares-da-Silva, Faculdade de Medicina da Universidade do Porto (FM/UP). €150,000.
Early Diagnosis of Alzheimer´s Disease: evaluation of recent classification criteria and proposal of new diagnostic tools. Maria Isabel Jacinto Santana, Hospitais da Universidade de Coimbra, E.P.E (HUC/UC). €166,000.
Does malaria increase susceptibility to tuberculosis? The role of malaria-pigment induced immune-suppression. Thomas Hänscheid, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €150,000.
Risk for cardiovascular events in chronic kidney disease patients under haemodialysis. Lipid profile, anemia, vascular access and inflammation. Alice Santos-Silva, Instituto de Biologia Molecular e Celular (IBMC/UP). €100,000.
PURINERGIC AND CHOLINERGIC CONTROL OF LUNG-RESIDENT INFLAMMATORY CELLS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASES. Carlos Manuel da Silva Robalo Cordeiro, Universidade de Coimbra (UC). €105,000.
Breast Cancer Diagnosis - A new PET Scanner developped in Portugal. Miguel de Sá e Sousa de Castelo Branco, Universidade de Coimbra (UC). €190,000.
New approaches in multiple sclerosis diagnosis: the role of the choroid plexus. João José Fernandes Cardoso de Araújo Cerqueira, Universidade do Minho (UM). €130,000.
Mutational spectrum and improvement in laboratory techniques applied to molecular diagnosis of neurological disorders. Isabel Alonso, Instituto de Biologia Molecular e Celular (IBMC/UP). €185,000.
Autonomic nervous system in recurrent renal stone disease. Maria Isabel de Sousa Rocha, Instituto de Medicina Molecular João lobo Antunes (IMM/FM/ULisboa). €50,000.
Molecular analysis of the Mucolipidosis II and III in Portugal: characterization of the mutational spectrum and relationship with clinical phenotypes. Sandra Catarina da Conceição Alves, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €74,000.
NEEDS FOR CARE ASSESSMENT IN MENTALLY DISORDERD INMATES. Fernando Miguel Teixeira Xavier, Faculdade de Ciências Médicas (FCM/UNL). €22,000.
Vitamin D, a candidate for new therapy of basal-like breast carcinomas. Fernando Schmitt, Instituto de Patologia e Imunologia Molecular (IPATIMUP/UP). €150,000.
Cognitive Training in Brain Disorders: Effectiveness of cognitive stimulation and development of a new tool for Portuguese clinicians. Adriana da Conceição Soares Sampaio, Universidade do Minho (UM). €160,000.
The relevance of HHV-6B in patients with Mesial Temporal Lobe Epilepsy (MTLE) due to Hippocampal Sclerosis (HS): implications in prevention and treatment. Maria Berta Silva, Instituto de Ciências Biomédicas Abel Salazar da universidade do Porto (ICBAS/UP). €100,000.
Impact of apoptosis regulatory genes in the clinical responses of myelodysplastic patients to hypomethylating agents. Sérgio Dias, Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE (IPO Lisboa). €65,000.
The PIRO Sepsis concept - implementation and validation of a new classification in Sepsis. Cristina GRANJA, Faculdade de Medicina da Universidade do Porto (FM/UP). €50,000.
RECONSTITUTION AND HOMEOSTHASIS OF THE IMMUNE SYSTEM FOLLOWING HIV-INFECTION. António Gil Pereira de Castro, Universidade do Minho (UM). €140,000.
Clinical and molecular study of familial lipoprotein disorders with increase cardiovascular risk. Mafalda Bourbon, Instituto Nacional de Saúde Dr. Ricardo Jorge (INSARJ). €120,000.